Sell Veri MedTech Holdings, Inc. (VRHI) stock to fund a goal
Calculator · free · no signup · VRHINeed cash for a goal? Plan the minimum-tax schedule to sell your vested Veri MedTech Holdings, Inc. (VRHI) shares and net a target amount by a target date, across tax years.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Inputs
Your equity
One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.
Lots
Plan
Estimates only. Not financial advice.
Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.
| Tax | $111,637 | $110,752 | $111,637 | $119,397 |
| Wealth @ target | $726,476 | $680,919 | $726,476 | $721,823 |
| Chance of shortfall | 2.5% | 0% | 2.5% | 4.8% |
Feasible
$400,051 net by 08/01/27
Total tax: $111,637 (federal $59,593, state $36,947, NIIT $15,097)
Schedule · Recommended
| Sale date | Shares | Tax | Net | Cumulative |
|---|---|---|---|---|
| 06/30/26 | 173 | $14,974 | $15,410 | |
| 07/31/26 | 300 | $26,124 | $42,233 | |
| 08/31/26 | 300 | $26,281 | $69,157 | |
| 09/30/26 | 300 | $26,434 | $96,180 | |
| 10/31/26 | 300 | $26,594 | $123,305 | |
| 11/30/26 | 300 | $26,749 | $150,529 | |
| 12/31/26 | 300 | $26,910 | $177,857 | |
| 01/31/27 | 300 | $27,073 | $205,289 | |
| 02/28/27 | 300 | $27,221 | $232,814 | |
| 03/31/27 | 300 | $27,385 | $260,444 | |
| 04/30/27 | 300 | $27,546 | $288,176 | |
| 05/31/27 | 300 | $27,712 | $316,013 | |
| 06/30/27 | 300 | $27,875 | $343,953 | |
| 07/31/27 | 300 | $28,043 | $372,000 | |
| 08/01/27 | 300 | $28,052 | $400,051 |
Risk vs wealth
Each dot is a possible plan. Right is riskier, up is more wealth left over.
Trajectory of cash netted
Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.
After the plan
You keep 3,627 shares worth $436,251 at the projected target-date price, invested for the next decision.
About Veri MedTech Holdings, Inc.
Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company.
OTC; cannabis telehealth.
Equity grants at Veri MedTech Holdings, Inc. typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).
Veri Medtech Holdings (OTC: VRHI) operates Veriheal, a telehealth platform founded in 2017 by Joshua Green and Samuel Adetunji that connects patients with state-licensed physicians for medical marijuana card certifications across multiple U.S. states. The Denver-based company has processed over 400,000 patient approvals through a network of roughly 400 physicians and reported cumulative revenue exceeding $100 million since inception, per a May 2025 company announcement. Veri Medtech filed an S-1 with the SEC in November 2025 seeking a $15 million Nasdaq uplisting at $4 per share, disclosing a going-concern risk tied to working capital deficits.
Sources: renaissancecapital.com · globenewswire.com
Equity comp at Veri MedTech Holdings, Inc.
- OTC Pink Sheet micro-cap (ticker VRHI) with a pending Nasdaq uplisting through a small follow-on offering. The equity plan permits both options and RSUs, though concrete grant terms are not publicly disclosed in detail. Liquidity is currently constrained by thin OTC trading volume rather than a vesting trigger.
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Sources: sec.gov
Researched 2026-05-11.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Veri MedTech Holdings, Inc..
If you hold vested Veri MedTech Holdings, Inc. (VRHI) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.
All Veri MedTech Holdings, Inc. tools → · Use the generic Stock Sale Funding Calculator for any company.
Veri MedTech Holdings, Inc. equity questions
- How much VRHI stock do I sell to fund a goal without overpaying tax?
- It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested VRHI shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
- Does Veri MedTech Holdings, Inc. grant ISOs, NSOs, or RSUs?
- Equity compensation at Veri MedTech Holdings, Inc. typically takes the form of incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs). Incentive stock options can trigger the alternative minimum tax (AMT) when you exercise. Restricted stock units are taxed as ordinary income when they vest.
- Do Veri MedTech Holdings, Inc. RSUs use double-trigger vesting?
- No. Veri MedTech Holdings, Inc. restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
One piece of the puzzle.
OptionsAhoy plans your Veri MedTech Holdings, Inc. equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.